Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells

• Michele Cea,

  Affiliations Department of Internal Medicine, University of Genoa, Genoa, Italy, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Debora Soncini,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Floriana Fruscione,

  Affiliation Advanced Biotechnology Center (ABC), Genoa, Italy

  ⨯
• Lizzia Raffaghello,

  Affiliation Laboratory of Oncology, IRCCS G. Gaslini, Genoa, Italy

  ⨯
• Anna Garuti,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Laura Emionite,

  Affiliation Animal Facility, National Cancer Institute, Genoa, Italy

  ⨯
• Eva Moran,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Mirko Magnone,

  Affiliation Section of Biochemistry, Department of Experimental Medicine, University of Genoa, Genoa, Italy

  ⨯
• Gabriele Zoppoli,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Daniele Reverberi,

  Affiliation Medical Oncology Division C, National Cancer Institute, Genoa, Italy

  ⨯
• Irene Caffa,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Annalisa Salis,

  Affiliation Section of Biochemistry, Department of Experimental Medicine, University of Genoa, Genoa, Italy

  ⨯
• Antonia Cagnetta,

  Affiliations Department of Hematology and Oncology, San Martino Hospital, Genoa, Italy, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Micaela Bergamaschi,

  Affiliation Department of Hematology and Oncology, San Martino Hospital, Genoa, Italy

  ⨯
• Salvatore Casciaro,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Ivana Pierri,

  Affiliation Department of Hematology and Oncology, San Martino Hospital, Genoa, Italy

  ⨯
• Gianluca Damonte,

  Affiliation Section of Biochemistry, Department of Experimental Medicine, University of Genoa, Genoa, Italy

  ⨯
• Filippo Ansaldi,

  Affiliation Department of Health Sciences, University of Genoa, Genoa, Italy

  ⨯
• Marco Gobbi,

  Affiliation Department of Hematology and Oncology, San Martino Hospital, Genoa, Italy

  ⨯
• Vito Pistoia,

  Affiliation Laboratory of Oncology, IRCCS G. Gaslini, Genoa, Italy

  ⨯
• Alberto Ballestrero,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Franco Patrone,

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• Santina Bruzzone ,

  Contributed equally to this work with: Santina Bruzzone, Alessio Nencioni

  Affiliation Section of Biochemistry, Department of Experimental Medicine, University of Genoa, Genoa, Italy

  ⨯
•  [ ... ],
• Alessio Nencioni

  Contributed equally to this work with: Santina Bruzzone, Alessio Nencioni

  * E-mail: A.Nencioni@gmx.net

  Affiliation Department of Internal Medicine, University of Genoa, Genoa, Italy

  ⨯
• [ view all ]
• [ view less ]